Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

Summary

This study aims to explore the potential for Tezepelumab-treated severe asthmatic patients to effectively and safely reduce their background maintenance medication while maintaining asthma symptom control.

Timeline

Start

2026-01-28

Primary completion

2027-08-07

Completion

2029-03-31

Drugs

Indications